Aug. 2 at 9:04 PM
$CRBU Look, a lot of us believe biotechs are going to create the next big rush of capital after/during the AI boom. Obviously, some people thought this a few years back about biotechs and lost money. It was too early back then to create anything of consequence. Just like early AI was not too impressive back then either. Now the technology is better, therapies are starting to work long term, people are surviving cancer and other diseases that would have killed them a few years back because of biotech. Like AI there may be a race for advancement between the us and China in biotech. People are going to want to live longer, better lives and gene editing has the potential to accomplish this for people, at some point. People will likely pay anything for some of these future therapies. What makes CRBU so interesting to me is that they are not only developing a promising cancer therapy, but they are refining a proprietary process for allowing these therapies to be off the shelf.
